The authors explained their findings as a stage-dependent regulation of circulating CD34+/CD133+ and CD34+ progenitor cells in patients with AD: these cells might be at a lower level in early AD but may be upregulated in moderate and severe AD where they are a part of the tissue healing mechanisms in the AD brain [36]. This evidence concerns the gene PROM1 and Alzheimer disease.